Patients with chronic myeloid leukemia after stem cell transplantation were studied with a sensitive quantitative PCR
Replicate real-time quantitative PCR uses RT-qPCR methods with 82 replicates per sample
Replicate real-time quantitative PCR increased assay sensitivity to ≥ 10−5.5 in 95% of studied cases
At 4 years after stem cell transplantation, all tested patients were negative for BCR-ABL including 5 in accelerated phase